Compound ID | 331
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Demonstrated potent activity against H. influenzae, Sreptococcus pneumoniae and the causers of community acquired tract infections |
| Description: | Cho Y, Kim M, Lee CS, Youn H. The in vitro activity of LB11058, a new parenteral Cephalosporin with activity against multiresistant Gram-positive bacteria. 42nd-ICAAC 2002;173 |
| Institute where first reported: | LG Life Sciences, South Korea |
| Year first mentioned: | 2002 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9872839 |
| Citations: |
|